Efficacy and Safety of Oral Gonadotropin-Releasing Hormone Antagonist, Relugolix, in Endometriosis: A Meta-Analysis of Randomized Clinical Trials

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
Full text 765 characters · extracted from oa-doi-fallback · click to expand
Sobral, Milene Vitória Sampaio; dos Santos, João Pedro Pereira; Vilela, Tania Aparecida Alves ; Pirolla, Rafaela da Cunha; Barreiros, Fernando Augusto MD, PhD; de Moraes, Marina Ayabe Gomes MD, MSc University of West São Paulo, São Paulo, Brazil The authors state that they have no proprietary interest in the products named in this article. All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. During the preparation of this work, the authors used ChatGPT 3.5 to enhance the readability and language of the text. After using this tool/service, the authors reviewed and edited the content as needed and assume full responsibility for the content of the published article.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-06-19T06:14:56.452680+00:00
pubmed
last seen: 2026-06-19T06:11:44.962913+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine